Search - tctmd.com

Displaying 1 - 20 of 1353

Sort: Relevancy | Date

News Conference News ACC 2026

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

Todd Neale

April 01, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

News Conference News ACC 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

Todd Neale

March 28, 2026

Presentation ACC 2026

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: The CHAMPION-AF Clinical Trial

Presenter: Saibal Kar

March 28, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

L.A. McKeown

March 19, 2026

News Daily News

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

Caitlin E. Cox

March 18, 2026

News Conference News CRT 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

L.A. McKeown

March 17, 2026

News Conference News CRT 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

L.A. McKeown

March 16, 2026

News Conference News CRT 2026

SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type

L.A. McKeown

March 16, 2026

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

L.A. McKeown

March 04, 2026

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

Todd Neale

March 04, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

News Conference News EAPCI 2026

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Caitlin E. Cox

February 25, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

Caitlin E. Cox

February 10, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

Advertisement

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

TCTMD’s Top 10 Most Popular Stories for March 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: The CHAMPION-AF Clinical Trial

What’s Going to Be Hot at ACC 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

CARPOOL Radial Access as Good as Femoral in PAD Procedures

SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type

CRT 2026: What to Expect in Washington, DC

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

TCTMD’s Top 10 Most Popular Stories for February 2026

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Meta-analysis Teases Out What Drives Success in M-TEER

TCTMD’s Top 10 Most Popular Stories for January 2026

TCTMD’s Biggest News of 2025

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content